MedTrace Logo

Ciclesonide vs Fluticasone Nasal Sprays in Nasal Poplyposis

NCT02665806 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2016-01-28

No results posted yet for this study

Summary

This study is designed to compare ciclesonide nasal spray once daily with fluticasone propionate aquas nasal spray BD, which is commonly prescribed in patients with nasal polyposis, in order to relieve symptoms of these patients.

Conditions

  • Chronic Rhinosinustis With Polyps

Interventions

DRUG

Ciclesonide

intranasal ciclesonide spray 200 µg once daily

DRUG

Fluticasone

fluticasone propionate aqueous nasal spray 200 µg twice a day

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Mohsen Naraghi, MD · Tehran University of Medical Sciences, Department of Otolaryngology-Head and Neck Surgery, Tehran, Iran

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-02-29
Completion
2016-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02665806 on ClinicalTrials.gov